TRCT
TMDI

Tower Research Capital (TRC)’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Tower Research Capital (TRC)’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,117
Closed -$2K – 6865
2022
Q1 		$2K Buy
+4,117
New +$2.39K ﹤0.01% 5685
2021
Q4 		– Sell
-800
Closed -$1K – 6845
2021
Q3 		$1K Buy
+800
New +$1.3K ﹤0.01% 5616

Other funds holding TMDI

EL
Essex LLC Deer Park, Illinois $659M AUM 41.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Tower Research Capital (TRC)'s TMDI Position: Q2 2022 in Review

Tower Research Capital (TRC) sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q2 2022, closing a stake of 4,117 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in TMDI in Q3 2021 and held it in 2 quarters. The position peaked at $2K in Q1 2022. 68 funds tracked by Wall St. Rank hold TMDI as of Q2 2022.

  • Tower Research Capital (TRC) reported no remaining Titan Medical Inc. Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 4,117 Titan Medical Inc. Ordinary Shares shares in Q2 2022, an estimated $2K.
  • Tower Research Capital (TRC) first reported a position in Titan Medical Inc. Ordinary Shares in Q3 2021 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s Titan Medical Inc. Ordinary Shares position peaked at $2K in Q1 2022.
  • 68 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q2 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2022, filed 15 Aug 2022.